2022-11-012022-11-012022-10-25Tour, James, Taniguchi, Cullen and Mason, Kathy, "Selective accretion of cytoprotectant in radiation-sensitive tissues and uses thereof." Patent US11478489B2. issued 2022-10-25. Retrieved from <a href="https://hdl.handle.net/1911/113781">https://hdl.handle.net/1911/113781</a>.https://hdl.handle.net/1911/113781The disclosure relates to the treatment of primary and metastatic cancer using radiation. Specifically, the disclosure relates to methods providing for the selective accretion of cytoprotective agent in tissues and/or organs, sensitive to radiation that are adjacent to malignant tumors prior to radiation of the tumors at a dose that otherwise would be toxic to the tissues and/or organs, but are necessary to achieve ablative outcome on the tumors.17engUtility patentUS11478489B2